Corvus Pharmaceuticals, Inc.
CRVS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,157 | -$7,998 | $15,193 | -$12,113 |
| Dep. & Amort. | $28 | $29 | $22 | $20 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,256 | $1,251 | $845 |
| Change in WC | -$550 | $2,893 | $152 | -$1,459 |
| Other Non-Cash | $1,113 | -$1,957 | -$24,881 | $4,242 |
| Operating Cash Flow | -$9,566 | -$5,777 | -$8,263 | -$8,465 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$113 | -$36 | $5 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$31,149 | -$39,475 | -$7,708 | -$20,361 |
| Inv. Sales/Matur. | $28,531 | $19,287 | $11,987 | $14,273 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,618 | -$20,301 | $4,243 | -$6,083 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $360 | $35,770 | $279 | $18,608 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $360 | $35,770 | $279 | $18,608 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11,824 | $9,692 | -$3,741 | $4,060 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,691 | $4,999 | $8,740 | $4,680 |
| End Cash | $2,867 | $14,691 | $4,999 | $8,740 |
| Free Cash Flow | -$9,566 | -$5,890 | -$8,299 | -$8,465 |